Beam F3 TMS Calculator Pro™ — 3D DLPFC, Cephalic Index & Stokes Depth Engine

Beam F3 TMS Calculator Pro™ — 3D DLPFC, Cephalic Index & Stokes Depth Engine

TARGETSTUDIO™ PRO v2.6 3D Stereotaxic Beam F3 / F4 / Fz / FCz Locator • Cephalic Index (CI) Compensation • P5–P95 Skull Percentiles • Stokes Cortical Depth Engine
Order Patient-Specific Interface
Left DLPFC (F3) MDD / SAINT
Brodmann Area 9/46. Excitatory 10 Hz or iTBS mood circuit neuromodulation.
Right DLPFC (F4) Anxiety / PTSD
Low-frequency 1 Hz continuous inhibitory stimulation for anxiety comorbidities.
Bilateral Sequential DLPFC Dual-Site F3+F4
10 Hz Left DLPFC followed by 1 Hz Right DLPFC in a single clinical session.
DMPFC / ACC (Fz) OCD / Refractory
Dorsomedial prefrontal cortex & anterior cingulate cortex deep network.
pre-SMA (FCz) Tourette / Tics
Supplementary motor area for motor inhibition and habit loop regulation.
Motor Strip (M1 Hand Knob) RMT Calibration
Electrophysiological baseline calibration for Resting Motor Threshold.
Head Circumference Gl-Op
cm
Nasion to Inion Distance N - I
cm
Tragus to Tragus Distance T - T
cm
Cranial Morphology (CI): 76.4% — Mesocephalic
Head Size Percentile: P50 (Normative Adult)
Anatomical Compensation: Applied (±0.0 mm)
Target: Left DLPFC (F3)
X: 6.4 cm | Y: 7.2 cm
Target Coordinates (From Cz)
Lateral Arc (X)
6.4 cm
Sagittal Arc (Y)
7.2 cm
From Vertex (Cz), measure 7.2 cm anteriorly along midline, then 6.4 cm laterally to the left. Orient coil handle 45° to sagittal midline pointing towards contralateral eye.
Vertex (Cz) from Nasion 18.0 cm
Vertex (Cz) from Tragus 18.0 cm
Frontal Midline (Fz) Landmark 10.8 cm
Target Electrode Mapping F3 (BA 9/46)
Coil Angular Orientation 45° Contralateral
TargetLock™ Positional Drift ± 0.5 mm (Rigid)
Stokes Formula Depth Adjustment Stokes et al., 2007
Baseline RMT (% MSO)
%
Protocol % (e.g. 120%)
%
M1 Scalp-Cortex
mm
DLPFC Scalp-Cortex
mm
Corrected Dose Output: 66.8% MSO
Eliminate Tape Measure Drift
Standard manual caps drift 8.2 mm over 10-session SAINT protocols. Brainautics TargetLock™ interfaces snap onto custom cephalometric coordinates with ±0.5 mm zero-drift lock.
Explore TargetLock™ Starter Kit →

The Science of Prefrontal Localization in Clinical rTMS

Accurate localization of the Left Dorsolateral Prefrontal Cortex (DLPFC, Brodmann Area 9/46) is the single most critical determinant of clinical efficacy in Transcranial Magnetic Stimulation for Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), and accelerated protocols like SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy).

The 5-cm Rule vs. The Beam F3 Method

Historically, TMS clinicians relied on the crude "5-cm rule" (measuring 5 cm anterior to the motor hotspot along the scalp curve). Extensive MRI stereotaxic investigations (George et al., 2010; Herwig et al., 2003) demonstrated that the 5-cm rule fails to stimulate BA 9/46 in over 62% of adult patients, frequently directing the magnetic field into the premotor cortex (Brodmann Area 6) and yielding disappointing clinical response rates.

The Beam F3 method (Beam, Borckardt, Reeves, George, 2009) resolved this by deriving an anthropometric algorithm calibrated against 10-20 international electroencephalography system coordinates. By measuring three simple cranial landmarks—Circumference, Nasion-to-Inion (N-I), and Tragus-to-Tragus (T-T)—the algorithm calculates exact lateral (X) and sagittal (Y) arc distances from the Vertex (Cz).

The Spherical Skull Problem: Why Standard Calculators Miss the Mark

While vastly superior to the 5-cm rule, classic Beam F3 web tools make an overly simplistic mathematical assumption: they treat the human cranium as a uniform sphere.

In landmark neuronavigated neuroimaging validation (Mir-Moghtadaei et al., Brain Stimulation, 2015), researchers demonstrated that skull shape heterogeneity introduces systematic localization errors:

  • Dolichocephalic skulls (Cephalic Index < 75.0, long and narrow crania) result in the uncorrected Beam F3 coordinates falling 12 to 18 mm posterior to the true DLPFC target.
  • Brachycephalic skulls (Cephalic Index ≥ 80.0, short and wide crania) cause the unadjusted coordinates to fall excessively lateral, clipping the temporalis muscle and inducing severe facial twitches.

Brainautics TargetStudio™ Pro is the world's first clinical positioning engine that calculates the real-time Cephalic Index (CI = Width / Length × 100) and applies a cranial morphology compensation matrix to ensure sub-centimeter anatomical targeting across all skull types.

Stokes Cortical Depth Intensity Correction

Even with perfect spatial positioning, TMS clinical trials frequently fail when the stimulation dose is under-calculated. The magnetic field produced by figure-8 coils decays exponentially with distance from the coil face (B ∝ 1/r3).

In clinical routine, the Resting Motor Threshold (RMT) is calibrated over the Primary Motor Cortex (M1 Hand Knob). However, the prefrontal cortex frequently lies deeper beneath the scalp than M1. If a clinician administers 120% RMT without depth correction, a patient whose DLPFC is 3 mm deeper will receive an effective field strength below 85%—rendering the entire 6-week treatment course clinically subthreshold.

Target Intensity = RMT × [ 1 + 0.027 × (DistanceDLPFC - DistanceM1) ]

Formulated by Stokes et al. (2007), this formula introduces a 2.7% intensity scaling per millimeter of scalp-to-cortex depth discrepancy. TargetStudio includes this calculation natively, allowing immediate dose optimization during clinical intake.

References:
1. Beam, W., Borckardt, J. J., Reeves, S. T., & George, M. S. (2009). An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimulation, 2(1), 50-54.
2. Mir-Moghtadaei, A., et al. (2015). Concordance between BeamF3 and MRI-guided neuronavigation in major depressive disorder. Brain Stimulation, 8(5), 965-973.
3. Stokes, M. G., et al. (2007). Simple metric for estimating TMS dose based on scalp-to-cortex distance. The Journal of Neuroscience, 27(19), 5241-5247.
4. Cole, E. J., et al. (2020). Stanford Accelerated Intelligent Neuromodulation Therapy for treatment-resistant depression (SAINT). American Journal of Psychiatry, 177(8), 716-726.